How M&A Approvals Work in South Korea for Foreign Buyers

Knowing exactly how M&A approvals work in South Korea for foreign buyers is the difference between a transaction that closes on schedule and one that stalls, or unravels entirely. South Korea layers three distinct regulatory regimes on top of one another: competition clearance through the Korea Fair Trade Commission (KFTC), foreign-investment notification under the Foreign Investment Promotion Act (FIPA), and sector-specific approvals administered by bodies such as the Financial Services Commission (FSC) and the Ministry of Food and Drug Safety (MFDS). At Ahnse Law Offices, I guide foreign acquirers through every stage of that process, from the first threshold analysis in due diligence to post-closing integration filings.

This guide maps the full buyer journey, signing, pre-closing regulatory filings, conditional clearances, closing and the first ninety days of compliance, so that in-house counsel, deal teams and international law firms can plan with confidence.

At-a-Glance Buyer’s Roadmap: Which Approvals Matter and When

Every foreign buyer targeting a Korean company needs to answer three questions before signing: does the deal trigger a KFTC merger notification, does it require a FIPA foreign-investment filing, and does the target operate in a sector that imposes its own approval layer? The answers shape the entire deal timetable, the conditions precedent in the acquisition agreement, and the litigation risk profile if anything is overlooked.

Quick checklist: signing → closing → post-closing

• Pre-signing. Run the KFTC threshold analysis, confirm FIPA notification or permission requirements, and identify every applicable sectoral regulator.
• Signing. Execute the acquisition agreement with conditions precedent for each required clearance; build in long-stop dates that accommodate the slowest approval.
• Pre-closing filings. Submit the KFTC merger notification, file the FIPA foreign-investor notification via KOTRA or a designated foreign-exchange bank, and lodge any sectoral approval applications.
• Review windows. KFTC conducts its preliminary and, where needed, extended review; FIPA notification is processed; sectoral regulators carry out their own assessments.
• Closing. Proceed only once all clearances are unconditional or conditions have been satisfied.
• Post-closing (first 90 days). Complete foreign-ownership registration, update the corporate registry, address employment and immigration matters, and file tax notifications.

Competition and Merger Control: KFTC Notification Thresholds, Filing Tests and Remedies

The Korea Fair Trade Commission administers Korea’s merger-control regime under the Monopoly Regulation and Fair Trade Act. Any transaction that meets the prescribed asset or turnover thresholds must be notified to the KFTC before it can close. The KFTC will then assess whether the combination is likely to restrict competition substantially, and it has the power to approve, impose conditions, or prohibit the deal outright.

Notification thresholds and who must file

A KFTC merger notification is required when both the acquiring party (or its enterprise group) and the target meet or exceed the statutory asset or turnover thresholds set out in the Act and its enforcement decrees. The thresholds are denominated in Korean won and are updated periodically by presidential decree. For foreign acquirers the calculation must include group-wide figures, so even a modest Korean target can trigger the filing obligation if the buyer’s global group is large enough. Both share acquisitions and asset acquisitions that amount to a business transfer can qualify as notifiable concentrations.

In my experience, the threshold analysis is best carried out during early due diligence, ideally before the letter of intent is finalised, because a filing obligation directly affects deal timing and the drafting of conditions precedent. I have seen foreign buyers learn of the KFTC filing requirement only after signing, which compresses the pre-closing window and introduces avoidable risk.

Pre-merger filing, remedies and conditional clearances

Korea operates a mandatory pre-closing notification system. Once a complete filing is accepted, the KFTC conducts a preliminary review within a statutory timeframe. If the preliminary review raises no competition concerns, the merger is cleared and the parties may proceed to closing. If concerns are identified, the KFTC may initiate an extended review, a more detailed investigation that includes market analysis, third-party consultations and, potentially, negotiations over remedies.

Remedies can be structural (divestitures, carve-outs) or behavioural (commitments on pricing, supply or access). Conditional clearances, where the KFTC approves the deal subject to specific undertakings, are common in transactions where the acquirer already has an overlapping Korean business. The remedy negotiation phase is often the most time-consuming part of the KFTC process, and it is critical that the acquisition agreement accommodates this possibility through sufficiently long conditionality periods.

Practical timeline for merger review in Korea and litigation risk

For straightforward transactions, KFTC clearance can be obtained within the statutory preliminary review period. Complex cases involving market overlaps or vertical integration concerns may take substantially longer, particularly if the review is extended and remedy discussions are needed. I advise clients to assume a conservative timeline when setting long-stop dates in the acquisition agreement.

Closing before obtaining KFTC clearance is a serious violation of Korean competition law. The KFTC has the authority to impose administrative fines for gun-jumping and, in the most extreme cases, can order the unwinding of a completed transaction. From a litigation perspective, premature closing also exposes the buyer to claims from minority shareholders, competitors or contractual counterparties who allege harm from the unapproved combination. In my practice, I treat the KFTC filing as a hard condition precedent, never a best-efforts obligation, in every deal where the thresholds are met or reasonably arguable.

Foreign Investment Promotion Act: When M&A Approvals Are Required for Foreign Buyers in South Korea

Alongside merger control, every foreign buyer acquiring equity in a Korean company must comply with the Foreign Investment Promotion Act. FIPA establishes a notification-based regime for most foreign investments, with a narrower category of transactions in strategically sensitive sectors requiring prior governmental permission before the investment can proceed.

Notification versus permission: which route applies

For the majority of cross-border share acquisitions, the FIPA requirement is a foreign-investor notification, a procedural filing that must be completed before the buyer remits acquisition funds to Korea. The notification is not an approval in the discretionary sense: provided the filing is properly completed and the required documents are in order, the investment may proceed. However, for transactions in designated restricted sectors, those touching on national security, public order or critical infrastructure, prior permission from the relevant ministry is required, and the investment cannot proceed until that permission is granted.

The distinction matters enormously for deal structuring. A notification-only transaction can usually be processed quickly and does not introduce meaningful conditionality risk. A permission-required transaction, by contrast, must be treated as a substantive regulatory approval with its own timeline and the possibility of refusal.

Where to file: KOTRA, foreign-exchange banks and delegated agencies

The foreign-investor notification can be filed through two primary channels. The first is KOTRA, the Korea Trade-Investment Promotion Agency, operating through its Invest KOREA division, which serves as the main governmental contact point for foreign investment facilitation. The second channel is a designated foreign-exchange bank in Korea, which can accept and process the notification on behalf of the government. Both routes are legally equivalent, although in practice I find that KOTRA’s Invest KOREA division provides more structured procedural guidance for complex transactions. The prescribed notification forms are available in both Korean and English on the Invest KOREA portal.

Practical checklist for investors filing under FIPA

• Corporate existence documents. Certificate of incorporation or equivalent, articles of association, and a good-standing certificate from the investor’s home jurisdiction.
• Investor identification. Passport copies for individual investors; corporate registration extracts and beneficial-ownership disclosures for entity investors.
• Transaction documents. Executed share purchase agreement or subscription agreement, board resolutions authorising the investment, and a valuation summary where applicable.
• Remittance plan. Details of the proposed fund transfer including the designated foreign-exchange bank, the source of funds and the expected remittance date.
• Sector-specific disclosures. Additional information required by the relevant ministry if the target operates in a restricted sector.

Sectoral Approvals Korea: Financial Services, Pharma, Telecom and Defence

Beyond the KFTC and FIPA, sector-specific regulators in Korea impose their own approval requirements on changes of corporate control. These sectoral approvals can be the most time-consuming element of a cross-border M&A transaction, and overlooking one can result in a licence revocation that destroys a substantial portion of the deal value.

Financial sector, FSC and FSS approvals

Acquisitions of banks, insurance companies, securities firms and other financial institutions require change-of-control approval from the Financial Services Commission. The FSC assesses the acquirer’s financial soundness, corporate governance standards and suitability to hold a controlling interest in a regulated entity. The Financial Supervisory Service (FSS) conducts the detailed supervisory review. Approval timelines can be significant, and I recommend initiating the FSC application immediately upon signing to avoid this becoming the binding constraint on the deal timetable.

Pharmaceuticals and medical devices, MFDS approvals

Where the target holds product marketing authorisations, manufacturing site approvals or clinical trial permits issued by the Ministry of Food and Drug Safety, a change of ownership may trigger requirements to update, transfer or reissue those authorisations. The MFDS operates its own review timeline, and buyers should conduct a thorough inventory of all MFDS-related permits during due diligence to plan for the necessary post-closing regulatory transitions.

Telecom, defence, broadcasting and other restricted sectors

Foreign ownership of Korean telecom carriers, defence contractors and terrestrial broadcasting companies is subject to statutory caps, ministerial screening and, in the case of defence, national-security reviews administered by the Ministry of Trade, Industry and Energy (MOTIE) and the Ministry of National Defence. For telecom, the Ministry of Science and ICT (MSIT) oversees foreign ownership limits, while the Korea Communications Commission (KCC) regulates broadcasting. Deals in these sectors require careful structural planning, often involving capped equity positions or voting trusts, to remain within the legal limits while achieving the buyer’s commercial objectives.

Practical Timeline Scenarios for Three Common Deal Structures

Timelines for M&A approvals in South Korea vary depending on the deal structure, the number of regulators involved and the complexity of any remedy negotiations. Below are three scenarios I encounter regularly with foreign buyers, each with a simplified timeline framework.

Public tender or takeover of a listed target

1. Week 0, Announcement and signing. Mandatory tender-offer rules under the Financial Investment Services and Capital Markets Act apply. Public disclosure is immediate.
2. Weeks 1–2, Parallel regulatory filings. KFTC merger notification, FIPA notification and any sectoral approval applications are filed concurrently.
3. Weeks 3–8, Review windows. KFTC preliminary review runs alongside the tender-offer period. Sectoral approvals proceed in parallel.
4. Weeks 8–12, Clearance and settlement. Tender settlement occurs once all regulatory conditions are satisfied or waived. If KFTC extended review is triggered, the timeline extends accordingly.

Private share acquisition

1. Day 0, Signing. Share purchase agreement executed with conditions precedent for all required clearances.
2. Days 1–14, Filings. KFTC notification, FIPA notification and sectoral applications submitted promptly after signing.
3. Weeks 3–8, Review and clearance. KFTC preliminary review, FIPA processing and sectoral assessments run concurrently.
4. Weeks 8–16, Closing. Target closing date set to accommodate the slowest approval, with a long-stop date providing a further buffer.

Asset acquisition

1. Day 0, Signing. Asset purchase agreement executed. KFTC notification required if the asset transfer constitutes a business transfer meeting the merger thresholds.
2. Days 1–14, Filings. FIPA notification filed if the buyer is establishing or expanding a foreign-invested enterprise. Transfer applications lodged for asset-level permits (MFDS product authorisations, for example).
3. Weeks 3–10, Review and permit transfers. KFTC review (if applicable), FIPA processing and asset-level permit transfers proceed.
4. Weeks 10–14, Closing and registration. Asset transfer completed; buyer registers business changes with relevant registries.

Risks, Remedies and Litigation Exposure for Foreign Buyers

In my litigation practice, the disputes I see most frequently in cross-border Korean M&A stem from missed or late regulatory filings. The consequences can range from administrative fines to forced unwinding, outcomes that are actively enforced by Korean regulators and that can generate follow-on litigation from third parties.

Penalties and sanctions for missed filings

The KFTC imposes administrative fines for failure to file a required merger notification, regardless of whether the transaction ultimately raises substantive competition concerns. Under FIPA, failure to file a foreign-investor notification can result in administrative penalties and may impair the investor’s ability to remit dividends, repatriate capital or enforce shareholder rights in Korean courts. Sectoral regulators can revoke operating licences held by the target, effectively destroying the asset the buyer paid for. Gun-jumping, closing before KFTC clearance, carries its own fine schedule and, in the worst case, an order to unwind the transaction.

How to remediate: voluntary disclosure and settlement

Where a filing has been missed, the most pragmatic first step is voluntary disclosure to the relevant authority. Korean regulators generally distinguish between inadvertent non-compliance that is promptly self-reported and deliberate evasion. A well-prepared remediation submission should include a candid explanation of the failure, evidence that the underlying transaction does not create competitive or policy concerns, and a proposal for prospective compliance. Settlement discussions can reduce the quantum of penalties and establish an agreed compliance framework going forward.

When litigation is needed

Litigation may arise in several ways. Competitors or minority shareholders may seek injunctions to prevent or reverse a transaction that closed without required approvals. The buyer may need to bring declaratory proceedings to establish the validity of its title where a regulatory challenge has cast doubt on the legality of the share transfer. Damages claims, by the seller, minority shareholders or even the target company, can follow if the regulatory failure causes financial loss. My strong advice to every foreign buyer is to treat the approval-mapping exercise as core risk management, not a compliance afterthought.

Post-Closing Compliance and Integration Checklist

Obtaining pre-closing clearances is only the midpoint of the regulatory journey. The first ninety days after closing require disciplined execution of post-closing obligations that, if neglected, can trigger enforcement action or impair the buyer’s ability to operate the acquired business.

Action list for the first 90 days

• Corporate registry filings. Update the target’s shareholder register, file director and representative-director changes with the competent Korean court registry, and register the foreign-investment completion with KOTRA or the designated foreign-exchange bank.
• Foreign-ownership registration. Obtain or update the foreign-investment registration certificate, this document is essential for remitting dividends and repatriating capital.
• Employment and labour compliance. Review employment contracts, collective bargaining agreements and any mandatory employee-notification obligations triggered by the change of control.
• Immigration. Arrange appropriate visa categories for foreign personnel deploying to the Korean operation, typically D-7 (intra-company transferee) or D-8 (corporate investor) visas.
• Tax reporting. File change-of-control tax notifications with the National Tax Service; assess withholding-tax obligations on the acquisition consideration and evaluate applicable treaty benefits.
• Ongoing sectoral reporting. Comply with continuing supervisory obligations to sectoral regulators, FSC periodic filings, MFDS update notifications, MSIT ownership reports and other sector-specific requirements.

Practical Templates and Reference Materials for Foreign Buyers

Assembling a tailored compliance checklist at the start of every transaction is the single most effective way to reduce M&A approval risk in South Korea. The following official resources provide practical starting points:

• FIPA notification forms. The prescribed foreign-investment notification forms are published by Invest KOREA and available for download from the KOTRA portal. I recommend completing these in consultation with Korean counsel to ensure accuracy and to address any bilingual discrepancies between the English and Korean versions.
• KFTC merger review guidance. The KFTC publishes its filing procedures, threshold calculations and review standards on its official English-language merger review page. Buyers should verify current thresholds at the start of every deal, as these are updated periodically by presidential decree.
• Sectoral approval checklists. The FSC, MFDS and MSIT each maintain English-language portals with procedural information that can form the basis of a sector-specific filing checklist. These are particularly valuable for financial-sector and pharma deals where the regulatory requirements are multi-layered.
• Sample SPA clauses. Well-drafted conditions precedent covering KFTC clearance, FIPA notification acceptance and sectoral approvals are essential. At Ahnse Law Offices, we maintain template clause libraries adapted to each deal type and sector combination.

Conclusion

Understanding how M&A approvals work in South Korea for foreign buyers is a prerequisite for any cross-border acquisition that aims to close efficiently and without litigation exposure. The interplay between KFTC merger control, FIPA foreign-investment notifications and sector-specific regulatory clearances creates a multi-layered compliance challenge that demands early mapping, disciplined execution and experienced local counsel. In my view, the acquirers who succeed in the Korean market are those who embed the approval roadmap into their deal strategy from day one, not those who treat regulatory filings as administrative tasks to address after signing. I welcome enquiries from foreign buyers, in-house teams and international law firms seeking practical guidance on any aspect of this process through our lawyer directory.

Sources

1. Korea Fair Trade Commission, Merger Review
2. Invest KOREA (KOTRA), Foreign Investment Procedures
3. Korea Legislation Research Institute, Official Law Portal (law.go.kr)
4. Financial Services Commission (FSC), Regulatory Guidance
5. Ministry of Food and Drug Safety (MFDS), Drug Approval Process
6. UNCTAD, Investment Policy Hub (FIPA Reference)